Vive la Résistance: T-cell Immunity in the Protection against SARS-CoV-2 Infection.

Publication Type Editorial Article
Authors McGary L, Vardhana S
Journal Cancer Discov
Volume 12
Issue 4
Pagination 892-894
Date Published 04/01/2022
ISSN 2159-8290
Keywords COVID-19
Abstract Fahrner and colleagues investigated the immune response of patients with cancer and cancer-free individuals to SARS-CoV-2 and found that a propensity toward an IL5-predominant Th2/Tc2 response was predictive of susceptibility to infection. The results of this study also suggest that a cellular response against the Spike 1 protein receptor binding domain (S1-RBD) region of the SARS-CoV-2 proteome contributes to protection and that mutations in this region may drive viral evolution and immune escape. See related article by Fahrner et al., p. 958 (8).
DOI 10.1158/2159-8290.CD-22-0080
PubMed ID 35373282
Back to Top